Generic Selzentry: An Overview
Selzentry™ (
maraviroc) is a prescription
HIV and
AIDS medication. It is part of a group of medications known as entry inhibitors. Selzentry is always used with other HIV medications and is usually reserved for people who have developed a resistance to other HIV medications.
Selzentry is made by Pfizer, Inc. It is currently under the protection of patents that prevent any generic Selzentry from being manufactured in the United States.
When Will Generic Selzentry Be Available?
The first patent for Selzentry currently expires in December 2019. This is the earliest possible date that a generic version of the drug could become available. However, other circumstances could come up to extend the exclusivity period beyond 2019. This could include such things as other patents for specific
Selzentry uses or lawsuits. Once the patent expires, several companies will likely begin manufacturing a generic Selzentry drug.
Is Maraviroc the Same as Generic Selzentry?
No -- maraviroc is the active ingredient in Selzentry, but is not a generic version of it. What can be confusing is that, oftentimes, the active ingredient of a drug is referred to as the "generic name." The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
